Satellos Bioscience (MSLE) Tax Provisions (2025 - 2026)

Satellos Bioscience's (MSLE) quarterly Tax Provisions came in at -$33000.0 in Q1 2026, down 152.38% year-on-year from $63000.0 in Q1 2025, and down 152.38% on a QoQ basis from $63000.0 in Q1 2025.

Satellos Bioscience (MSLE) Tax Provisions (2025 - 2026) Analysis & Trends

Satellos Bioscience (MSLE) has 2 years of Tax Provisions data on file, last reported at -$33000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 125,146.46
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 31.86 Mn
4 NuCana 279.75 Bn 279.75 Bn - 188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 179.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Satellos Bioscience 148.71 Mn 148.71 Mn - -33,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -33,000.00
Mar 31, 2025 63,000.00